Germo Gericke, MD
Dr. Germo Gericke serves as a Scientific Advisor to Aktis Oncology. Dr. Gericke is a clinical development expert with a special focus on oncology and radiopharmaceuticals. He is Chief Medical Officer and EVP Research and Development (R&D) of Ariceum Therapeutics, and previously served as Chief Medical Officer and Head of R&D at Advanced Accelerator Applications (AAA), a Novartis company. Earlier, Dr. Gericke led Novartis global development programs in oncology and endocrinology. Having joined Novartis in 2001 from McKinsey & Company, he also gained strategic and commercial experience across a range of therapeutic and geographic areas. Dr. Gericke studied medicine at Charité University Hospital in Berlin and holds an MD from the University of Heidelberg.